Interleukin-10 (IL-10) is an important immunoregulatory cytokine. The recent characterisation of the proximal 5Ј flanking region of IL-10 led to the identification of the promoter region. Two polymorphic dinucleotide repeats and 10 single nucleotide polymorphisms (SNPs) have been identified and suggested to be useful genetic markers in several diseases. We have sequenced a further 5275 bp from −9296 to −4021 of the distal part of the 5Ј flanking region of the human IL-10 gene from the cosmid clone pWE15-4/11. Our sequence analysis reveals a high density of Alu-repeats within the IL-10 gene locus, including three novel, related structures which we term Alu-IL10 (A-C). Using three overlapping PCR products spanning 5110 bp of this distal part of the IL-10 gene the following single base pair substitutions were identified: at −8571
Introduction
Recently we isolated the proximal 5Ј-flanking region of interleukin-10 (IL-10), characterized the promoter region and described a 4200-bp fragment.
1-4 IL-10 is an important multifunctional cytokine and a key regulatory component of many aspects of the immune response. 5 IL-10 exerts a wide spectrum of biological activities in vitro and in vivo and is implicated in the regulation of the inflammatory and immune responses. [5] [6] [7] The ability of IL-10 to block activation of cytokine synthesis and several accessory cell functions renders this cytokine a potent suppressor of the effector functions of macrophages, T cells and NK-cells. [8] [9] [10] Among the different cell types affected by IL-10, monocytes/macrophages and lymphocytes appear to be particularly modified with regard to their function, morphology, and phenotype.
The influence of IL-10 in the basic biology of the human immune system is reflected in its involvement with a range of autoimmune and malignant diseases. 6, 7 In particular, IL-10 may contribute to the development and progression of diseases which involve the prolifer- ation and differentiation of B cells, or the growth of human B-cell lymphomas, where its expression can be profoundly dysregulated 11, 12 IL-10 is able to promote the proliferation and differentiation of B cells and the production of autoantibodies. 11, 13 Indeed, elevated levels of IL-10 are found in the serum of systemic lupus erythematosus (SLE) patients and the number of IL-10 secreting cells is also increased. 14, 15 Recent reports indicate that this cytokine may contribute to Epstein-Barr virus (EBV)-associated transformation. [16] [17] [18] [19] [20] It has been shown that IL-10 is an autocrine growth factor for AIDSassociated lymphoma cells in vitro and that IL-10 is a pathogenic factor for lymphoma development in huS-CID-mice. 18, 21 Increased levels of IL-10 were detected in sera of patients with non-Hodgkin's lymphomas as well as in Hodgkin's disease. [22] [23] [24] [25] High IL-10 levels were also associated with poor prognosis in acute infectious diseases, particularly meningococcal meningitis. 26, 27 The expression of IL-10 is tightly regulated and the levels of constitutive expression in normal leukocytes are extremely low. In contrast, IL-10 is expressed in a range of activated cell-types, including monocytes, T cells and B cells. In addition, IL-10 is apparently constitutively secreted by EBV-immortalised B cells and EBV-positive Burkitt's lymphoma (BL) cells. 16, 17, 19, 28 However, the mechanism of the IL-10 induction in B cells is still unclear.
Levels of IL-10 secretion are variable between individuals and almost 70% of such intra-individual variation is heritable. 29 It is reasonable therefore to examine the human IL-10 gene for polymorphic elements associated with such variation. We isolated the proximal 5Ј-flanking region of IL-10, characterised the promoter region and described a 4200-bp fragment as highly polymorphic. [1] [2] [3] [4] Two informative dinucleotide repeats (microsatellites) were described. [2] [3] [4] It was demonstrated that these microsatellites combine to form haplotypes which are associated with differential IL-10 production. 29 The haplotype IL10.R2/IL10.G14 was associated with highest IL-10 secretion overall, whereas the haplotype IL10.R3/IL10.G7 was associated with lowest IL-10 secretion. Thus, the ability to secrete IL-10 can vary in man according to the genetic composition of the IL-10 locus. We and others also demonstrated the presence of multiple single nucleotide polymorphisms (SNPs) in the human IL-10 5Ј flanking region and we recently showed how these combine with the microsatellite alleles to form four major haplotype families (IL10.01, IL10.02, IL10.03 and IL10.04) associated with differential IL-10 production. 4, [30] [31] [32] However, the variation in IL-10 secretion attributable to these haplotypes or their component individual loci does not account for the variation in IL-10 secretion observed between individuals. 30, 33, 34 In addition, our original description of the IL-10 5Ј flanking region and recent publications demonstrated the presence of several positive and negative regulatory regions in the 4200 bp described. 1, [35] [36] [37] [38] [39] These observations suggest that there may be other, as yet unidentified DNA variations within the IL-10 gene locus, contributing to variation in IL-10 secretion.
In order to establish the molecular basis for further studies to determine genetic variations in IL-10 secretion and predispositions to infectious, autoimmune and malignant diseases, we set out to characterise the distal 5Ј flanking region of the IL-10 gene.
Results
Sequence of the distal human IL-10 5Ј flanking region Using oligonucleotides which allowed direct sequencing 5Ј of the IL10.R microsatellite the defined sequence upstream of the human IL-10 gene was extended on the recently described cosmid pWE15-4/11.
1 Because of the presence of a 26 residue mononucleotide T repeat which was difficult to sequence directly, a genomic walking procedure was performed. Cosmid and genomic DNA were digested with RsaI or HindII followed by a subsequent adaptor ligation, which allowed us to generate a 1386-bp fragment (RsaI) and a 1006-bp fragment (HindII). The corresponding amplimers were sequenced in both directions using the corresponding adaptor (T3Ad) and IL-10 specific primers (IL10/40R). Further primer walking on the cosmid led to the description of an additional 5110 bp giving new information about the distal part of the 5Ј flanking region of the IL-10 gene. The sequence of the human IL-10 gene from −3901 to −9296 is shown in Figure 1 . This sequence has been added to our original deposition and can be accessed from the GenEMBL database under the original accession number, X78437. Figure 1 shows the sites of the IL10.R microsatellite and a mononucleotide repeat comprising a stretch of 26 T residues, the polymorphic nature of which remains to be determined. 
Demonstration of potential transcription factor binding sites
Previously we had found that the known 4200 bp of the IL-10 promoter could direct the expression of a luciferase reporter gene in different lymphoid cell lines, when inserted in the reverse orientation (own unpublished observation). We therefore searched for potential promoters, transcription factor binding sites related to cytokines as well as for potential open reading frames. Using the NIX software package (available to registered users of the UK Medical Research Council's human genome mapping project website: http://www.hgmp.mrc.ac.uk) potential promoters were identified at positions: −8010 and −6340 on the coding strand and positions −8524, −8010, −6340 and −4021 on the noncoding strand of the IL-10 gene (Figure 2 ). The potential transcription factor binding sites were defined using TRANSFAC software and our own collection of motifs recently identified as important for the regulation of cytokine promoters, including NFB, NF-IL6, Oct1, CREB, AP1, GM-CSF; their locations are shown in Figure 2a . As seen on the figure the dense cluster of potential transcription factor binding sites previously described between −3000 and −4000 has to be extended to −4500 because in this part of the new sequence we identified the highest density of potential functional motifs, including a TATA box at −4021, NFB and AP1 sites. A half site Alu repeat is localised at −7332/−7220 (Alu-IL10B) with homology to Alu-J. Overall, four complete Alu sequences (Alu-IL10A, Alu-IL10C, Alu-IL10D and Alu-IL10E) and one Alu half site (Alu-IL10B) within 18 kb of our new 5Ј flanking sequence, the previously existing 5Ј flanking sequence and the genomic sequence containing the coding elements and the 3ЈUTR were identified. It should be noted that the density of repeat elements is higher in the newly-defined distal 5Ј flanking region compared to the proximal 5Ј flanking region of the IL-10 gene. These new IL-10 Alu sequences are compared against their nearest homologous sequences in Figure 3a while their evolutionary relationships are presented in Figure 3b . 40 Novel point mutations in the distal 5Ј flanking region of human IL-10 gene Genomic DNAs from European donors and from African donors were sequenced in both directions. A total of 16 individuals were sequenced. These were compared with each other and with the sequence from the pWE15-4/11 cosmid. This led to the discovery of new SNPs within the IL-10 5Ј flanking region, summarised in Table 1 . Variant
Genes and Immunity bases were found at positions: −8571 C/T, −8531 G/A, −6752 A/T, −6208 G/C and −5402 C/G. The pWE15-4/11 cosmid had the following base composition: −8571 C, −8531 G, −6752 A, −6208 G and −5402 C, which we adopted as the reference sequence. Because of the low sample number tested no linkage analysis was performed, however each SNP was observed more than once. Individuals who were −8751 C/C and C/T were identified, as were −8531 G/G and G/A and −5402 C/C and C/G. All possible combinations were observed at −6752 and −6208 and these two SNP loci may be closely linked since homozygotes were always observed to be A/A+G/G or T/T+C/C. The SNPs at positions −8571 and −8531 are part of the Alu-repeat Alu-IL10A. The SNP −8571 is within a potential SP1 binding site and the presence of the 'T' variant would disrupt this.
In addition to the described sequence variations, a trinucleotide insertion/deletion (indel) AGG mutation was noted at −7400 in five individuals. This deletion was only observed as a heterozygous genotype in the samples analysed. This three base pair indel is near to the Alu-J repeat, which is itself a disrupted Alu repeat. . This alignment allowed us to localise the IL-10 sequence within the cosmid pWE15-4/11 near to the T3 site of the cosmid. In addition we used the deposited information to identify neighbouring sequences by PCR and direct sequencing. This revealed that the fragments 7076-9365 and 32892-38895 (AC068122) are immediately 5Ј from the described 5Ј distal part of the IL-10 5Ј flanking region.
Discussion
The transcriptional control of the human IL-10 gene is not well-defined, but it is known to be influenced by other cytokines, particularly tumour necrosis factor, IL-12 and interferon-gamma. 10, 41, 42 Several studies have demonstrated that, where gene transcription is influenced by TNF, this influence is exerted through complexes of NFB and REL proteins. 43, 44 The dense clustering of potential cytokine response elements between −3000 to −4500 suggests that this portion of the human IL-10 gene may indeed be the area through which proinflammatory cytokines exert influence over IL-10 transcription, although this hypothesis will be subject to experimental verification (Figure 2a ). mainly accomplished by crossing-over between Alus and retrotransposition. The existence of a half of an Alu-J repeat at −7332/−7220 (Alu-IL10B) strongly suggests that a recombination event has happened in this region. Furthermore, the existence of a heterozygous deletion of AGG at position −7400 nearby this disrupted Alu-J repeat may indicate the position of an active recombination site. In addition the nearby Alu-repeat Alu-IL10A at −8770/−8514 showed highest homology only after separate alignments to Alu-Yb8 and Alu-Sz and we speculate in addition that this Alu repeat could be the result of a recombination event between two related Alu families. Further analysis of the identified Alu repeats within the IL-10 gene locus would provide more evidence for this suggestion.
ATC[C/T]GCC CGT[G/A]AGC CCA[A/T]CAC AAT[G/C]TGG AGG[C/G]GTT GGA(GGA)GAG
The various polymorphic elements in the IL-10 promoter and 5Ј regions have been associated with susceptibility to disease. The best-defined example of this is in SLE where we and others have shown association between IL10.G microsatellite genotype and disease susceptibility. 45, 46 In addition certain SNP genotypes have been associated with disease, or the presence of particular SLE symptoms or disease severity, for example the presence of neuropsychiatric disease. [47] [48] [49] In less-well replicated studies various markers and alleles in the IL-10 locus have been associated with rheumatoid arthritis, ulcerative colitis and asthma amongst others. 47, 48, [50] [51] [52] [53] [54] [55] It has been shown that patients suffering from chronic hepatitis C and carrying an IL-10 haplotype associated with high IL-10 production capacity showed less response to IFN-alpha therapy. 56 There is also a growing number of reports concerning the potential use of IL-10 DNA sequence variations in risk prediction in the field of transplantation.
53,57 For renal transplantation it was shown that rejection episodes and severe rejections of transplants may correlate with 'high producer' genotypes of the IL-10 SNP at −1087 and of TNF at position −308 of the recipient. 58 However in a study by Allen et al 33 dysregulated IL-10 production associated with UVB-induced local immunosuppression did not correlate with any of the known IL-10 polymorphisms. This suggests that additional, as yet uncharacterised DNA variations within the IL-10 gene locus may be associated with this and related phenomenon. 30, 33, 34 In addition to the IL10.G and IL10. In the future, this information could be used to analyse their frequency and geographical appearance to be useful in their application to epidemiological studies in autoimmune, infectious and malignant diseases. The sequence variations observed so far suggest an geographic specificity between the Caucasian or the African individuals. This however has to be analysed in more detail.
IL-10 is a central component of the immune response. It offers control over inflammatory and cell-mediated immunological mechanisms. 59 This is reflected in its apparent involvement in many immunological disease states, especially malignant, autoimmune and infectious diseases. Recent evidence has also shown that IL-10 is a target for many viruses in their attempt to subvert the human immune system. [60] [61] [62] The area of chromosome 1 where human IL-10 is encoded is rich with genes encoding proteins important for immune reactions; for example, components of the complement system (RCA = regulator of complement activation). These genes are adjacent to our location for the IL-10 gene and the genes for many of the Fc-gamma receptors are also nearby as is the cell-surface structure CD34. 63 Several lines of evidence indicate that these RCA genes share a common ancestor from which they originated by multiple events of gene duplication. 63 Like other cytokines, IL-10 does not act in isolation but functions within a cytokine network. Recent reports indicate the existance of genes (mda-7, IL-19) with homology to IL-10 located on chromosome 1q31/32. 64, 65 On chromosome 12 two other IL-10 homologues IL-22 and Ak155 which are grouped together with IFN-gamma were identified. 66, 67 If the RCA gene cluster is the result of multiple gene duplications, it sounds logical to suggest, that this also could happens with an ancestor gene of the IL-10 gene family and the polymorphic variants we found might affect mda-7 or IL-19 regulation.
The DNA sequence variations described in this report appear to be present in Caucasians and the limited number of analysed individuals suggest that they are likely to be common. However further studies will be required to determine their true frequency in Caucasians and other ethnic groups. Thus our structural analysis of the distal 5Ј UTR may form the basis for further detailed studies about their structure and functional significance in normal physiology and human diseases.
Materials and methods
Sequencing the human IL-10 5Ј flanking region As a prelude to sequencing the 5Ј flanking region of the human IL-10 gene, a cosmid genebank (Stratagene Europe, Amsterdam, The Netherlands) from human placenta was screened for IL-10 using two different hybridisation probes, as previously described. 1, 4 The nucleotide sequence was determined using the ABI Big Dye Terminator sequencing kit (Applied Biosystems, Foster City, CA, USA). The sequences were analysed on an ABI373
Genes and Immunity sequencer using ABI software. We have defined the DNA sequence up to position −9296 from the transcription start site of the human IL-10 gene (with the base immediately preceding the 'A' of the ATG taken as position +30). This sequence has been deposited in the Genebank and EMBL databases as HSINTL10 with accession number X78437 (1996 update, D Kube; 2000 update, D Kube); oligonucleotides used to prime the sequencing reaction are summarised in Table 2 .
Genome walking
The method is based on the separate digestion of genomic DNA with each of two restriction enzymes creating blunt ends (in this protocoll: RsaI or HindII). After digestion a T3-adaptor is ligated to the DNA. Using a biotinylated primer from a known sequence, a linear PCR is performed making use of the T3 adaptor to allow with a subsequent magnetic purification of the single strand. This purified single strand is amplified with the biotinylated oligonucleotide and the corresponding adaptor primer. For specificity it is recommended to use a nested PCR. One g of DNA (cosmid, genomic DNA) was digested with RsaI or HindII (Roche Diagnostics, Mannheim, Germany). The digested DNA was precipitated. The DNA pellet was dissolved in 50 pmole of the corresponding adaptors. The following oligonucleotides (Eurogentec, Seraine, Belgium, for all used oligonucleotides in genome walking, all other oligonucleotides purchased from Interaktiva, Germany) have been used after phosphorylation using polynucleotide kinase according to the manufacturer (Roche Diagnostics): T3Ad: 5Ј GGAGATCTCGAAATTAACCCTCACTAAAGGG; T3AdR: 5Ј CCCTTTAGTGAGGGTTAATTTCGAGATCTCCGCA.
After adaptor ligation using TAKARA ligation kit (Takara Shuzo, Otsu, Japan) the reaction mix was heat inactivated by incubation at 70°for 10 min followed by a purification using the Qiagen PCR purification kit (Qiagen, Hilden, Germany). Afterwards a linear PCR was performed using Pfu polymerase (Stratagene) and a biotinylated IL-10 specific primer (5Ј ATCACTTTAGCTGC AGAGGAATCT). The amplimers were heat inactivated by incubation at 70°for 10 min and chilled on ice before performing the magnetic separation. Magnetic-Streptavidin coated beads were used as recommended by the manufacturer (Promega GmbH, Mannheim, Germany). The single strand DNA was eluted using sterile water and processed directly to a nested PCR using Pfu polymerase and T3Ad and the IL-10 specific primer −3963R (5Ј TCTGTGTGTGCTTATGCAAATAGATTTTG) as primers. 1/1000 of this PCR reaction was used for an additional seminested PCR using T3Ad/−3981R (5Ј GG AGATCTAATAGATTTTGGAGGGTGCATTCTACAG). The amplimers were extracted from the agarose gel using the QiaExII kit (Qiagen). The purified amplimers were sequenced directly using the adaptor primer or a corresponding IL-10 specific primer.
The following software and websites have been used for the sequence analysis: http://www.girinst.org/Repbase †Update-LoginForm.html. 68, 69 
